Literature DB >> 10371473

Infertility following pelvic inflammatory disease.

A J Pavletic1, P Wölner-Hanssen, J Paavonen, S E Hawes, D A Eschenbach.   

Abstract

OBJECTIVE: To assess the frequency of infertility after pelvic inflammatory disease (PID) and factors important in postinfectious tubal damage in an urban population at high risk for sexually transmitted diseases.
METHODS: From a cohort of 213 women with PID documented by laparoscopy and/or endometrial biopsy, 58 women (27% of the initial cohort) were interviewed by phone 2 to 9 years after an index episode of PID. Data regarding the initial history, physical examination, microbiology, laparoscopic, and serologic findings, and data concerning interval contraception, subsequent pregnancy, subsequent infection, and chronic pelvic pain were compared among those with and without infertility at follow up.
RESULTS: Nineteen (40%) of the 48 women not using contraception were involuntarily infertile after the index episode of PID. Compared with those who had an interval pregnancy, infertile women were older (P = 0.02), more likely to have a history of infertility prior to the index episode of PID (P = 0.001), and were more likely to have occluded or partially occluded fallopian tubes (P = 0.03), peritubal adhesions (P = 0.007), or perihepatic adhesions (P = 0.02) seen by laparoscopy performed during the index episode. Surprisingly, recovery of Chlamydia trachomatis was negatively related to infertility (P = 0.001), although a similar proportion of both groups had chlamydia immunoglobulin M antibody (40% vs. 31%). Chlamydia heat shock protein was weakly related to infertility (P = 0.08). The isolation of Neisseria gonorrhoeae was not significantly different between groups (53% vs. 57%).
CONCLUSIONS: The high rate of postinfection infertility found was probably related to a combination of tubal damage before and during the index episode of PID. Prevention of recurrent PID and better understanding of the pathophysiology of postinfection tubal damage (which may differ between chlamydia and gonorrhea) is needed to develop more effective strategies to reduce permanent tubal damage.

Entities:  

Mesh:

Year:  1999        PMID: 10371473      PMCID: PMC1784727          DOI: 10.1002/(SICI)1098-0997(1999)7:3<145::AID-IDOG6>3.0.CO;2-6

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  23 in total

1.  Prevalence and correlates of antibody to chlamydial heat shock protein in women attending sexually transmitted disease clinics and women with confirmed pelvic inflammatory disease.

Authors:  L O Eckert; S E Hawes; P Wölner-Hanssen; D M Money; R W Peeling; R C Brunham; C E Stevens; D A Eschenbach; W E Stamm
Journal:  J Infect Dis       Date:  1997-06       Impact factor: 5.226

2.  Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy.

Authors:  L Jacobson; L Weström
Journal:  Am J Obstet Gynecol       Date:  1969-12-01       Impact factor: 8.661

3.  Treatment of acute non-tuberculous salpingitis with antibiotics alone and in combination with glucocorticoids. A prospective double blind controlled study of the clinical course and prognosis.

Authors:  V Falk
Journal:  Acta Obstet Gynecol Scand       Date:  1965       Impact factor: 3.636

4.  Long-term sequelae of acute pelvic inflammatory disease. A retrospective cohort study.

Authors:  S Safrin; J Schachter; D Dahrouge; R L Sweet
Journal:  Am J Obstet Gynecol       Date:  1992-04       Impact factor: 8.661

5.  Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease.

Authors:  D E Moore; L R Spadoni; H M Foy; S P Wang; J R Daling; C C Kuo; J T Grayston; D A Eschenbach
Journal:  Lancet       Date:  1982-09-11       Impact factor: 79.321

6.  Infertility after acute salpingitis with special reference to Chlamydia trachomatis.

Authors:  L Svensson; P A Mårdh; L Weström
Journal:  Fertil Steril       Date:  1983-09       Impact factor: 7.329

7.  Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin.

Authors:  D E Soper; N J Brockwell; H P Dalton
Journal:  Am J Obstet Gynecol       Date:  1992-09       Impact factor: 8.661

8.  Correlation between serum antichlamydial antibodies and tubal factor as a cause of infertility.

Authors:  R B Jones; B R Ardery; S L Hui; R E Cleary
Journal:  Fertil Steril       Date:  1982-11       Impact factor: 7.329

9.  Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results.

Authors:  L Weström; R Joesoef; G Reynolds; A Hagdu; S E Thompson
Journal:  Sex Transm Dis       Date:  1992 Jul-Aug       Impact factor: 2.830

10.  Association between antibody to the chlamydial heat-shock protein and tubal infertility.

Authors:  B Toye; C Laferrière; P Claman; P Jessamine; R Peeling
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

View more
  10 in total

Review 1.  Status of adolescent pelvic inflammatory disease management in the United States.

Authors:  Maria Trent
Journal:  Curr Opin Obstet Gynecol       Date:  2013-10       Impact factor: 1.927

2.  Efficacy of a motivational behavioral intervention to promote chlamydia and gonorrhea screening in young women: a randomized controlled trial.

Authors:  Mariam R Chacko; Constance M Wiemann; Claudia A Kozinetz; Kirk von Sternberg; Mary M Velasquez; Peggy B Smith; Ralph DiClemente
Journal:  J Adolesc Health       Date:  2009-08-03       Impact factor: 5.012

3.  Clinician perspectives on management of adolescents with pelvic inflammatory disease using standardized patient scenarios.

Authors:  Maria Trent; Harold Lehmann; Arlene Butz; Qiang Qian; Jonathan M Ellen; Kevin D Frick
Journal:  Sex Transm Dis       Date:  2013-06       Impact factor: 2.830

4.  New sexual partners and readiness to seek screening for chlamydia and gonorrhoea: predictors among minority young women.

Authors:  M R Chacko; C M Wiemann; C A Kozinetz; R J Diclemente; P B Smith; M M Velasquez; K von Sternberg
Journal:  Sex Transm Infect       Date:  2006-02       Impact factor: 3.519

5.  Young women's perspective of the pros and cons to seeking screening for chlamydia and gonorrhea: an exploratory study.

Authors:  Mariam R Chacko; Kirk von Sternberg; Mary M Velasquez; Constance M Wiemann; Peggy B Smith; Ralph DiClemente
Journal:  J Pediatr Adolesc Gynecol       Date:  2008-08       Impact factor: 1.814

6.  Efficacy of two sperm preparation techniques in reducing non-specific bacterial species from human semen.

Authors:  Prabath K Abeysundara; Dmab Dissanayake; Prasantha S Wijesinghe; Rrdp Perera; Aan Nishad
Journal:  J Hum Reprod Sci       Date:  2013-04

7.  The Diagnostic Properties of Medical History in the Diagnosis of Tubal Pathology among Subfertile Patients.

Authors:  Egle Tvarijonaviciene; Ruta Jolanta Nadisauskiene; Kristina Jariene; Valdemaras Kruminis
Journal:  ISRN Obstet Gynecol       Date:  2012-01-22

8.  Interaction of microbiology and pathology in women undergoing investigations for infertility.

Authors:  Joseph Debattista; Caroline M Gazzard; Robyn N Wood; John A Allan; Janet M Allan; Anthony Scarman; Miranda Mortlock; Peter Timms; Christine L Knox
Journal:  Infect Dis Obstet Gynecol       Date:  2004 Sep-Dec

9.  Acquisition of the capsule locus by horizontal gene transfer in Neisseria meningitidis is often accompanied by the loss of UDP-GalNAc synthesis.

Authors:  Stephanie N Bartley; Shakeel Mowlaboccus; Christopher A Mullally; Keith A Stubbs; Alice Vrielink; Martin C J Maiden; Odile B Harrison; Timothy T Perkins; Charlene M Kahler
Journal:  Sci Rep       Date:  2017-03-14       Impact factor: 4.379

10.  Prevalence of 7 sexually transmitted organisms by multiplex real-time PCR in Fallopian tube specimens collected from Saudi women with and without ectopic pregnancy.

Authors:  Ahmed Mohamed Ashshi; Sarah Abdullah Batwa; Seham Yahia Kutbi; Faizah Ahmed Malibary; Mohamed Batwa; Bassem Refaat
Journal:  BMC Infect Dis       Date:  2015-12-15       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.